Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals, Inc. is grouped at the issuer level across 1 linked ticker lifecycle, combining public listing, delisting, source, and shareholder outcome records from the archive.
Lifecycle Map
Issuer enters the archive
Apr 1, 2021Anebulo Pharmaceuticals, Inc. is represented as an issuer-level entity with 1 linked public-market ticker lifecycle.
Delisting event
Feb 17, 2026Removed from listing - SEC Form 25 filed.
SourceANEB stopped trading
Feb 17, 2026ANEB is linked to Anebulo Pharmaceuticals, Inc. and ended with final status "delisted".
Source
Entity Graph
Anebulo Pharmaceuticals, Inc.issuedANEB
ANEBlisted onNASDAQ
ANEBresulted inunknown
Source-Backed Claims
- Anebulo Pharmaceuticals, Inc. issued a press release announcing its financial results for the quarter ended December 31, 2025 on February 12, 2026.8-K
- Anebulo Pharmaceuticals, Inc. is incorporated in Delaware with the IRS Employer Identification Number 85-1170950.8-K
- Anebulo Pharmaceuticals, Inc. trades its common stock on The Nasdaq Stock Market LLC under the trading symbol ANEB.8-K
- Richard Anthony Cunningham signed the Form 8-K on behalf of Anebulo Pharmaceuticals, Inc. on February 12, 2026.8-K
Associated Tickers
Public-market security lifecycles tied to this issuer record.